What are the different types of urinary incontinence and their recommended first‑line and second‑line treatments?

Types of Urinary Incontinence and Treatment Recommendations

Urinary incontinence in women is classified into three main types—stress, urgency, and mixed—each requiring distinct first-line behavioral interventions before considering pharmacologic or surgical options. 1

Classification of Urinary Incontinence Types

Stress Urinary Incontinence

• Involuntary urine loss occurring with physical activities that increase intra-abdominal pressure, including coughing, sneezing, laughing, or exercise 1, 2
• Results from urethral sphincter failure and inability to retain urine during pressure increases 1
• Affects approximately 25% of young women, increasing to 75% in elderly women 1

Urgency Urinary Incontinence

• Involuntary urine loss accompanied by a sudden, compelling urge to void that cannot be deferred 1
• Often associated with overactive bladder syndrome, which includes urgency with or without incontinence, frequency, and nocturia 1, 3
• Caused primarily by detrusor overactivity with involuntary bladder contractions 3

Mixed Urinary Incontinence

• Combination of both stress and urgency incontinence symptoms occurring in the same patient 1
• The distinction between types becomes less clear in older women 1
• Requires addressing both stress and urgency components simultaneously 2

---

First-Line Treatment Recommendations

For Stress Urinary Incontinence

• Pelvic floor muscle training (PFMT) is the definitive first-line treatment, involving repeated voluntary pelvic floor muscle contractions (Kegel exercises) taught and supervised by a healthcare professional 1, 2
• PFMT supervised by healthcare professionals is more than 5 times as effective as no active treatment and significantly superior to unsupervised training 2
• Can reduce incontinence episodes by more than 50% with high-quality evidence supporting this approach 2
• Weight loss and exercise programs are essential for obese women (BMI ≥30), with a number needed to treat of 4 for symptom improvement 1, 2

For Urgency Urinary Incontinence

• Bladder training is the primary initial treatment, involving scheduled voiding with progressively longer intervals between bathroom trips 1, 2
• This behavioral therapy extends the time between voiding episodes and has moderate-quality evidence for effectiveness 1
• Adding PFMT to bladder training does not improve outcomes compared with bladder training alone for pure urgency incontinence 2

For Mixed Urinary Incontinence

• Combined PFMT plus bladder training is the first-line approach, addressing both stress and urgency components simultaneously 1, 2
• Weight loss benefits the stress component more than the urgency component in obese women 2
• Minimum 3 months of supervised conservative therapy should be attempted before escalating treatment 2

---

Second-Line Treatment Recommendations

For Stress Urinary Incontinence

• Systemic pharmacologic therapy is NOT recommended and should be avoided, as no medications have proven effective for stress incontinence 1, 2
• This represents a critical pitfall—using medications for stress incontinence wastes time and resources 2
• Surgical options (synthetic midurethral slings, retropubic suspension, fascial slings) are reserved for women who fail ≥3 months of supervised conservative therapy 2

For Urgency Urinary Incontinence

• Pharmacologic treatment should be initiated only if bladder training was unsuccessful 1
• All antimuscarinic agents show similar efficacy: oxybutynin, tolterodine, darifenacin, solifenacin, fesoterodine, and trospium 1, 2
• Base medication selection on tolerability, adverse effect profile, ease of use, and cost rather than efficacy, as all agents demonstrate comparable effectiveness 1, 2
• Solifenacin and fesoterodine are preferred due to dose-response effects and lower discontinuation rates from adverse effects 2
• Anticholinergic adverse effects (dry mouth, constipation, cognitive impairment) are the major reason for treatment discontinuation and should be discussed upfront 2

For Mixed Urinary Incontinence

• Target the urgency component first with antimuscarinic medications after behavioral interventions have been attempted for at least 3 months 2
• Solifenacin and fesoterodine demonstrate modest benefit (less than 20% absolute risk difference versus placebo) with dose-response effects 2
• Synthetic midurethral slings can address both components in 40-50% of cases but should only be considered after adequate conservative therapy trial 2

---

Critical Implementation Considerations

Common Pitfalls to Avoid

• Never skip behavioral interventions—bladder training and PFMT have strong evidence and must always be attempted first 2
• Do not use systemic pharmacologic therapy for stress incontinence—it is ineffective and represents wrong treatment for the wrong condition 1, 2
• Do not proceed to surgery without minimum 3 months of supervised conservative therapy 2
• Counsel patients about anticholinergic side effects upfront to set realistic expectations and improve adherence 2

Modifiable Risk Factors to Address

• Obesity is a significant modifiable risk factor requiring weight loss intervention 1, 3
• Smoking, caffeine consumption, constipation, and excessive fluid intake can exacerbate symptoms and should be addressed 1, 3
• Vaginal atrophy in postmenopausal women may benefit from vaginal estrogen therapy 3

Definition of Treatment Success

• Clinically successful treatment reduces incontinence episode frequency by at least 50% 1, 2
• No harms have been identified in studies of behavioral interventions like PFMT or weight loss programs 2